PMID- 15984537
OWN - NLM
STAT- MEDLINE
DCOM- 20050706
LR  - 20151119
IS  - 0385-0684 (Print)
IS  - 0385-0684 (Linking)
VI  - 32
IP  - 6
DP  - 2005 Jun
TI  - [Tumor markers in malignant lymphoma].
PG  - 883-92
AB  - For malignant lymphoma, there is no highly sensitive or specific tumor marker for 
      diagnosis. However, some tumor markers such as cell surface marker or karyotypic 
      analysis are useful for diagnosis combined with other clinical and pathological 
      information. International Prognostic Index (IPI), Follicular Lymphoma 
      International Prognostic Index (FLIPI), and International Prognostic Score (IPS) 
      are useful to predict prognosis, and utilized to decide therapeutic strategy of 
      aggressive non-Hodgkin's lymphoma (NHL), follicular lymphoma and Hodgkin's 
      lymphoma, respectively. Non-specific biological markers such as soluble 
      interleukin-2 receptor (sIL-2 R) are utilized to evaluate therapeutic effect. In 
      this paper, we describe about the significance of these tumor markers in 
      malignant lymphoma.
FAU - Kato, Harumi
AU  - Kato H
AD  - Dept. of Hematology and Cell Therapy, Aichi Cancer Center, Central Hospital, 
      Nagoya, Japan.
FAU - Ogura, Michinori
AU  - Ogura M
LA  - jpn
PT  - English Abstract
PT  - Journal Article
PT  - Review
PL  - Japan
TA  - Gan To Kagaku Ryoho
JT  - Gan to kagaku ryoho. Cancer & chemotherapy
JID - 7810034
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Receptors, Interleukin-2)
SB  - IM
MH  - Biomarkers, Tumor/*blood
MH  - Female
MH  - Hodgkin Disease/*diagnosis/mortality/pathology
MH  - Humans
MH  - Lymphoma, Non-Hodgkin/*diagnosis/genetics/mortality/pathology
MH  - Lymphoproliferative Disorders/*diagnosis/mortality
MH  - Male
MH  - Middle Aged
MH  - Prognosis
MH  - Receptors, Interleukin-2/*blood
MH  - Survival Rate
RF  - 78
EDAT- 2005/06/30 09:00
MHDA- 2005/07/07 09:00
CRDT- 2005/06/30 09:00
PHST- 2005/06/30 09:00 [pubmed]
PHST- 2005/07/07 09:00 [medline]
PHST- 2005/06/30 09:00 [entrez]
PST - ppublish
SO  - Gan To Kagaku Ryoho. 2005 Jun;32(6):883-92.